Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 13 Mar 2023 for Lucira Health, Inc., €7,929.
Filing timeline
BuySaleAnthony Joseph Allen
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Anthony Joseph Allen: trading record in brief
Anthony Joseph Allen (senior executive) discloses dealings in Lucira Health, Inc. to SEC (Form 4). Between 30 September 2021 and 3 March 2023, the trades on record add up to 6 filings.
Every open-market trade on record is a sale: 5 sales worth €43k. The rest of the record consists of 1 share grant. So far in 2023, the count stands at no purchases and 1 sale.
The record was last updated on 13 March 2023 with an open-market sale (€7,929) in Lucira Health, Inc. Typically, a trade is published a median of 6 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anthony Joseph Allen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
8,405 shares@ US$1.0023.7% of flowCommon StockSEC:0001209191-23-018219:0
4,263 shares@ US$0.161.9% of flowCommon StockSEC:0001209191-22-062409:0
3,429 shares@ US$0.333.3% of flowCommon StockSEC:0001209191-22-060495:0
17,052 shares@ US$1.3971.1% of flowCommon StockSEC:0001209191-22-051033:0
197,240 shares0Common StockSEC:0001209191-21-058566:0
5 of 5 declarations
